Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: A phase II dose-ranging study

European Heart Journal

Volumn 28, Issue 9, 2007, Pages 1109-1116

  Džavík, Vladimir ^a   Cotter, Gad ^b   Reynolds, Harmony R ^c   Alexander, John H ^b   Ramanathan, Krishnan ^c   Stebbins, Amanda L ^b   Hathaway, David ^d   Farkouh, Michael E ^c   Ohman, E Magnus ^e   Baran, David A ^f   Prondzinsky, Roland ^g   Panza, Julio A ^h   Cantor, Warren J ⁱ   Vered, Zvi ^j   Buller, Christopher E ^k   Kleiman, Neal S ^l   Webb, John G ^m   Holmes, David R ⁿ   Parrillo, Joseph E ^o   Hazen, Stanley L ^q   Gross, Steven S ^p   Harrington, Robert A ^b   Hochman, Judith S ^c   more..

^a TORONTO GENERAL HOSPITAL   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d Arginox Pharmaceuticals   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^g MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^h Washington Hospital   (United States)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j ASSAF HAROFEH MEDICAL CENTER   (Israel)

^k VANCOUVER GENERAL HOSPITAL   (Canada)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m ST PAUL S HOSPITAL   (Canada)

ⁿ MAYO CLINIC   (United States)

^o Department of Anesthesiology   (United States)

^p Department of Obstetrics Gynecology   (United States)

^q LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

Acute myocardial infarction; Cardiogenic shock; Inflammation; L N monomethyl arginine (L NMMA); Nitric oxide synthase

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; KIDNEY DISEASE; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; STROKE; TREATMENT OUTCOME; URINARY DYSFUNCTION;

AGED; ENZYME INHIBITORS; FEMALE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; SHOCK, CARDIOGENIC;

EID: 34548301578     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm075     Document Type: Article

References (24)

1. Wu AH, Parsons L, Every NR, Bates ER. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002;40:1389-1394.
2. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999;341:625-634.
3. Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S, Forman R, Desvigne-Nickens P, Jacobs AK, Slater JN, LeJemtel TH. One-year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190-192.
4. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006;295:2511-2515.
5. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998-3002.
6. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med 1999;131:47-59.
7. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
8. Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 2000;108:374-380.
9. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 2005;165:1643- 1650.
10. Cotter G, Kaluski E, Blatt A, Milovanov O, Moshkovitz Y, Zaidenstein R, Salah A, Alon D, Michovitz Y, Metzger M, Vered Z, Golik A. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation 2000;101:1358-1361.
11. Cotter G, Kaluski E, Milo O, Blatt A, Salah A, Hendler A, Krakover R, Golick A, Vered Z. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J 2003;24:1287-1295.
12. Hochman JS, Sleeper LA, Godfrey E, McKinlay SM, Sanborn T, Col J, LeJemtel T. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. Am Heart J 1999;137:313-321.
13. Shun Z, Silverberg A, Chang CK, Ouyang P. Dunnett's many-to-one test and least square means. J Biopharm Stat 2003;13:17-28.
14. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30.
15. Digerness SB, Harris KD, Kirklin JW, Urthaler F, Viera L, Beckman JS, Darley-Usmar V. Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic Biol Med 1999;27:1386-1392.
16. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
17. Recchia FA. Role of nitric oxide in the regulation of substrate metabolism in heart failure. Heart Fail Rev 2002;7:141-148.
18. Ullrich R, Scherrer-Crosbie M, Bloch KD, Ichinose F, Nakajima H, Picard MH, Zapol WM, Quezado ZM. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation 2000;102:1440-1446.
19. Wildhirt SM, Schulze C, Conrad N, Kornberg A, Horstman D, Reichart B. Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion-implications for iNOS-mediated myocardial stunning. Thorac Cardiovasc Surg 1999;47:137-143.
20. Gealekman O, Abassi Z, Rubinstein I, Winaver J, Binah O. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume - overload heart failure. Circulation 2002;105:236-243.
21. Yamamoto S, Tsutsui H, Tagawa H, Saito K, Takahashi M, Tada H, Yamamoto M, Katoh M, Egashira K, Takeshita A. Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure. Circulation 1997;95:1111-1114.
22. Wildhirt SM, Suzuki H, Wolf WP, Dudek R, Horstman D, Weismueller S, Reichart B. S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. Biochem Biophys Res Commun 1996;227:328-333.
23. Zhang Y, Bissing JW, Xu L, Ryan AJ, Martin SM, Miller FJ Jr, Kregel KC, Buettner GR, Kerber RE. Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. J Am Coll Cardiol 2001;38:546-554.
24. Hollenberg SM, Cunnion RE, Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 1993;264:H660-H663.